Thanks to technology and the convenience of our modern lifestyle, we are far less active today than previous generations. But how have our bodies adjusted to that massive physical slow-down? In this episode, we speak with endocrinologist and clinical scientist Professor Katherine Samaras, who is working every day to improve lives.

Thanks to technology and the convenience of our modern lifestyle, we are far less active today than previous generations. But how have our bodies adjusted to that massive physical slow-down? In this episode, we speak with endocrinologist and clinical scientist Professor Katherine Samaras, who is working every day to improve lives.

We dive deep into the minds of our amazing researchers to find out how they tick and how they are working to make our lives better.

We dive deep into the minds of our amazing researchers to find out how they tick and how they are working to make our lives better.

Medical Minds

What’s the link between blood sugar and dementia?

https://api.omny.fm/orgs/acbb53f8-dca0-419a-b44f-af49001056ab/clips/3556fda5-1d03-4330-82e1-b0b8016b3e11/transcript

Immunotherapy has revolutionised the treatment of many blood cancers, harnessing the immune system so our bodies can fight back. But for solid tumours, like pancreatic cancer with a survival rate of just 13%, that breakthrough has remained frustratingly out of reach. 

In this episode, we explore why the immune system struggles to attack these tumours and how the physical environment inside cancers can shape the way immune cells behave.

We hear from Garvan's Associate Professor Maté Biro, whose research maps how cells move inside of tumours, with the goal of uncovering new strategies to improve cancer treatment.

Immunotherapy has revolutionised the treatment of many blood cancers, harnessing the immune system so our bodies can fight back. But for solid tumours, like pancreatic cancer with a survival rate of just 13%, that breakthrough has remained frustratingly out of reach.&nbsp;
In this episode, we explore why the immune system struggles to attack these tumours and how the physical environment inside cancers can shape the way immune cells behave.
We hear from Garvan's Associate Professor Mat&eacute; Biro, whose research maps how cells move inside of tumours, with the goal of uncovering new strategies to improve cancer treatment.

Calling killer cells to action

Arthritis affects millions of people, but the underlying causes are still not fully understood. What makes the immune system that normally protects us suddenly attack our joints? And why do arthritis flares seem to arrive without warning?

In this episode, we explore how certain immune cells or signals might be responsible for switching inflammation on.

We hear from Garvan's Dr Etienne Masle-Farquhar, who is mapping these processes in both rheumatoid arthritis and osteoarthritis, with the goal of predicting flares earlier and guiding more effective treatment.

Arthritis affects millions of people, but the underlying causes are still not fully understood. What makes the immune system that normally protects us suddenly attack our joints? And why do arthritis flares seem to arrive without warning?
In this episode, we explore how certain immune cells or signals might be responsible for switching inflammation on.
We hear from Garvan's Dr Etienne Masle-Farquhar, who is mapping these processes in both rheumatoid arthritis and osteoarthritis, with the goal of predicting flares earlier and guiding more effective treatment.

Arthritis: uncovering pathways to better treatment   

https://api.omny.fm/orgs/acbb53f8-dca0-419a-b44f-af49001056ab/clips/693e3518-8816-44e3-b70f-b3b00147ab9f/transcript

For decades, the fight against cancer has focused on killing the tumour cell. We treated cancer like an isolated entity that needed to be destroyed – but what if we’ve been looking at the wrong target?

In this episode, we delve into the critical insight that cancer is not just a rogue cell – it’s an entire ecosystem – and that ecosystem is the key to unlocking a new class of cures.

We hear from Garvan's Dr Ankur Sharma, who is using precision technology to dissect how the environment around liver cancers allows them to grow unchecked. The ultimate goal for this research is to develop better diagnostics and treatments for this deadly cancer.

For decades, the fight against cancer has focused on killing the tumour cell. We treated cancer like an isolated entity that needed to be destroyed &ndash; but what if we&rsquo;ve been looking at the wrong target?
In this episode, we delve into the critical insight that cancer is not just a rogue cell &ndash; it&rsquo;s an entire ecosystem &ndash; and that ecosystem is the key to unlocking a new class of cures.
We hear from Garvan's Dr Ankur Sharma, who is using precision technology to dissect how the environment around liver cancers allows them to grow unchecked. The ultimate goal for this research is to develop better diagnostics and treatments for this deadly cancer.

Liver cancer: discovering the next generation of therapy targets

https://api.omny.fm/orgs/acbb53f8-dca0-419a-b44f-af49001056ab/clips/e8a23dde-e99f-4d93-8323-b38d0189a6fd/transcript

What’s the link between blood sugar and dementia?

In 1 playlist(s)

Medical Minds

Social links

Follow podcast

Recent clips